ResearchMoz

Pharmaceutical Market Research Reports & Industry Analysis

Our coverage in Pharmaceuticals Industry includes large MNC pharmaceutical companies, mid-sized & specialty pharmaceutical companies, off patent or generic drug manufacturers, biotechnology and life sciences companies, contract research companies. We also cover regulatory guidance, contract sales, manufacturing technologies and raw materials in the pharmaceuticals space.

The extensive research & analysis provides us with insight that is a valuable resource for decision-making in this highly vital sector. Our approach and methodology is will enable you a quick and effective understand the key insights of Pharmaceuticals Industry, thus enabling you to respond as market evolves.

Pharmaceutical

Browse reports in Pharmaceutical

Displaying 401 to 430 (of 3140 records)
Pages: « Prev  9 10 11 12 13 14 15 16 17 18   Next »
EpiCast Report: Colorectal Cancer Epidemiology Forecast to 2022
Dec 2012   |   By - GlobalData
EpiCast Report: Colorectal Cancer Epidemiology Forecast to 2022 Summary Colorectal cancer is the third most common cancer in men and second most common cancer in women. GlobalDatas epidemiologists expect the number of incident and prevalent cases of colorectal cancer in the US, Germany, Italy, Spain, the UK, Japan, India, and China to increase during the forecast...
$3995
EpiCast Report: Chronic Heart Failure Epidemilogy Forecast to 2022
Dec 2012   |   By - GlobalData
EpiCast Report: Chronic Heart Failure Epidemilogy Forecast to 2022 Summary The World Health Organization (WHO) estimated that there were approximately 5.70 million incident cases of heart failure in the world, with 0.80 million cases occurring in the Americas, 1.30 million cases in Europe, and 1.40 million cases in South East Asia (WHO, 2004). The overall...
$3995
Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals
Dec 2012   |   By - GlobalData
Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals Summary GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in...
$1000
Addiction - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Addiction Pipeline Review, H2 2012 Global Markets Directs, 'Addiction Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic...
$2000
Cognitive Disorders - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Cognitive Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Cognitive Disorders Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cognitive Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Herpes Infections - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Herpes Infections Pipeline Review, H2 2012 Global Markets Directs, 'Herpes Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Herpes Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Arteriosclerosis - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Arteriosclerosis Pipeline Review, H2 2012 Global Markets Directs, 'Arteriosclerosis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Arteriosclerosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Post-Operative Pain - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Post-Operative Pain Pipeline Review, H2 2012 Global Markets Directs, 'Post-Operative Pain Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Post-Operative Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Adenocarcinoma Of The Gastroesophageal Junction Pipeline Review, H2 2012 Global Markets Directs, 'Adenocarcinoma Of The Gastroesophageal Junction Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Adenocarcinoma Of The Gastroesophageal Junction, complete with latest updates, and...
$2000
Thrombosis - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Thrombosis Pipeline Review, H2 2012 Global Markets Directs, 'Thrombosis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Thrombosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
H5N1 Infection (Avian Influenza) Pipeline Review, H2 2012 Global Markets Directs, 'H5N1 Infection (Avian Influenza) Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for H5N1 Infection (Avian Influenza), complete with latest updates, and special features on late-stage and...
$2000
Aplastic Anemia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Aplastic Anemia Pipeline Review, H2 2012 Global Markets Directs, 'Aplastic Anemia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Aplastic Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved...
$2000
Dementia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Dementia Pipeline Review, H2 2012 Global Markets Directs, 'Dementia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Dementia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic...
$2000
Gliosarcoma - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Gliosarcoma Pipeline Review, H2 2012 Global Markets Directs, 'Gliosarcoma Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Gliosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Chemotherapy Induced Nausea and Vomiting Pipeline Review, H2 2012 Global Markets Directs, 'Chemotherapy Induced Nausea and Vomiting Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Nausea and Vomiting, complete with latest updates, and special features on...
$2000
Rhabdomyosarcoma - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Rhabdomyosarcoma Pipeline Review, H2 2012 Global Markets Directs, 'Rhabdomyosarcoma Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Rhabdomyosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Ulcers - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Ulcers Pipeline Review, H2 2012 Global Markets Directs, 'Ulcers Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic...
$2000
Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Streptococcus Pneumoniae (Pneumococcus) Infections Pipeline Review, H2 2012 Global Markets Directs, 'Streptococcus Pneumoniae (Pneumococcus) Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections, complete with latest...
$2000
Reperfusion Injury - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Reperfusion Injury Pipeline Review, H2 2012 Global Markets Directs, 'Reperfusion Injury Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Reperfusion Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Chemotherapy Induced Neutropenia Pipeline Review, H2 2012 Global Markets Directs, 'Chemotherapy Induced Neutropenia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Neutropenia, complete with latest updates, and special features on late-stage and...
$2000
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Review, H2 2012 Global Markets Directs, 'Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with...
$2000
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Wet (Neovascular / Exudative) Macular Degeneration Pipeline Review, H2 2012 Global Markets Directs, 'Wet (Neovascular / Exudative) Macular Degeneration Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with latest...
$2000
Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Gastroesophageal (GE) Junction Carcinomas Pipeline Review, H2 2012 Global Markets Directs, 'Gastroesophageal (GE) Junction Carcinomas Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Gastroesophageal (GE) Junction Carcinomas, complete with latest updates, and special features...
$2000
Seasonal Allergic Rhinitis - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Seasonal Allergic Rhinitis Pipeline Review, H2 2012 Global Markets Directs, 'Seasonal Allergic Rhinitis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Seasonal Allergic Rhinitis, complete with latest updates, and special features on late-stage and discontinued...
$2000
Fanconi Anemia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Fanconi Anemia Pipeline Review, H2 2012 Global Markets Directs, 'Fanconi Anemia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Fanconi Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in...
$2000
Diabetic Neuropathic Pain - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Diabetic Neuropathic Pain Pipeline Review, H2 2012 Global Markets Directs, 'Diabetic Neuropathic Pain Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Neuropathic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Thalassemia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Thalassemia Pipeline Review, H2 2012 Global Markets Directs, 'Thalassemia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Thalassemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Retinopathy - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Retinopathy Pipeline Review, H2 2012 Global Markets Directs, 'Retinopathy Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Retinopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Lymphoblastic Lymphoma - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Lymphoblastic Lymphoma Pipeline Review, H2 2012 Global Markets Directs, 'Lymphoblastic Lymphoma Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Lymphoblastic Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews...
$2000
Ependymoma - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Ependymoma Pipeline Review, H2 2012 Global Markets Directs, 'Ependymoma Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ependymoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
 
Displaying 401 to 430 (of 3140 records)
Pages: « Prev  9 10 11 12 13 14 15 16 17 18   Next »